The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
330 jobs Number of planned job creations
Announcement Date
2 February 2026
Employment effect (start)
1 February 2026
Foreseen end date
31 October 2026
Description
The pharmaceutical company Lek, owned by the Swiss group Sandoz, is investing in Lendava, creating 330 new jobs.
Construction is under way on a factory to manufacture active ingredients for similar biological medicines in Lendava. An investment of over €540 million will create around 330 new jobs in the Prekmurje region, including approximately 180 high value-added positions. The centre is expected to open in 2026.
Of all 3,024 employees in Lek, 27 percent are employed in Lendava. Almost two-thirds of new hires are under the age of 35, indicating a generational transition and development momentum.
Eurofound (2026), Lek, Business expansion in Slovenia, factsheet number 204204, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/204204.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
